Attached files
| file | filename |
|---|---|
| EX-99.1 - EX-99.1 - MARTEK BIOSCIENCES CORP | exhibit1.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
| Date of Report (Date of Earliest Event Reported): | March 2, 2010 |
Martek Biosciences Corporation
__________________________________________
(Exact name of registrant as specified in its charter)
| Delaware | 0-22354 | 52-1399362 |
|
_____________________ (State or other jurisdiction |
_____________ (Commission |
______________ (I.R.S. Employer |
| of incorporation) | File Number) | Identification No.) |
| 6480 Dobbin Road, Columbia, Maryland | 21045 | |
|
_________________________________ (Address of principal executive offices) |
___________ (Zip Code) |
| Registrant’s telephone number, including area code: | 410-740-0081 |
Not Applicable
______________________________________________
Former name or former address, if changed since last report
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 2.02 Results of Operations and Financial Condition.
On March 2, 2010, Martek issued a press release announcing its financial results for the fiscal quarter ended January 31, 2010. A copy of Martek’s press release is furnished as Exhibit 99.1 to this Item 2.02.
Item 9.01 Financial Statements and Exhibits.
d) Exhibits
The following is furnished as an Exhibit to this Current Report on Form 8-K.
Exhibit No. 99.1
Press Release dated March 2, 2010 issued by Martek Biosciences Corporation (Furnished pursuant to Item 2.02)
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Martek Biosciences Corporation | ||||
| March 2, 2010 | By: |
/s/ Peter L. Buzy
|
||
|
|
||||
| Name: Peter L. Buzy | ||||
| Title: Chief Financial Officer, Treasurer and Executive Vice President for Finance and Administration | ||||
Exhibit Index
| Exhibit No. | Description | |
|
|
|
|
|
99.1
|
Press Release dated March 2, 2010 issued by Martek Biosciences Corporation (Furnished pursuant to Item 2.02) |